Latest & greatest articles for HIV Test

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on HIV Test or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on HIV Test and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for HIV Test

121. Rapid HIV-1 testing during labor: a multicenter study. Full Text available with Trip Pro

Rapid HIV-1 testing during labor: a multicenter study. Timely testing of women in labor with undocumented human immunodeficiency virus (HIV) status could enable immediate provision of antiretroviral prophylaxis.To determine the feasibility and acceptance of rapid HIV testing among women in labor and to assess rapid HIV assay performance.The Mother-Infant Rapid Intervention At Delivery (MIRIAD) study implemented 24-hour counseling and voluntary rapid HIV testing for women in labor at 16 US (...) hospitals from November 16, 2001, through November 15, 2003. A rapid HIV-1 antibody test for whole blood was used.Acceptance of HIV testing; sensitivity, specificity, and predictive value of the rapid test; time from blood collection to patient notification of results.There were 91,707 visits to the labor and delivery units in the study, 7381 of which were by eligible women without documentation of HIV testing. Of these, 5744 (78%) women were approached for rapid HIV testing and 4849 (84%) consented

2004 JAMA

122. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States

), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) in donated blood were examined. The strategies considered were: serological (antibody and antigen) screening (SS); SS plus minipool (MP) nucleic acid testing (NAT); SS plus MP-NAT without p24 antigen (-p24); SS plus individual (ID) NAT -p24; SS plus ID-NAT -p24/antibody to hepatitis B core antigen (anti-HBc), (but retaining hepatitis B surface antigen, HbsAg); and SS plus ID-NAT -p24/HBsAg (but retaining anti-HBc). Type of intervention (...) States. Vox Sanguinis 2004; 86(1): 28-40 PubMedID Other publications of related interest AuBuchon JP, Birkmeyer JD, Busch MP. Cost-effectiveness of expanded human immunodeficiency virus- testing protocols for donated blood. Transfusion 1997;37:45-51. Jackson BR, Busch MP, Stramer SL. The cost-effectiveness of NAT for HIV, HCV and HBV in whole-blood donations. Transfusion 2003;43:721-9. Indexing Status Subject indexing assigned by NLM MeSH Blood Donors; Cost-Benefit Analysis; HIV Infections /diagnosis

2004 NHS Economic Evaluation Database.

123. Rapid testing strategies for HIV-1 serodiagnosis in high-prevalence African settings

by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Three different testing algorithms for human immunodeficiency virus (HIV) serodiagnosis were studied. A single, highly sensitive rapid antibody test (Abbott Determine) was compared against: (i) serial algorithm, where positive results on the first test (Abbott Determine) were confirmed with a more specific second test (Trinity Capillus); and (ii) a parallel algorithm, where each specimen was tested (...) Rapid testing strategies for HIV-1 serodiagnosis in high-prevalence African settings Rapid testing strategies for HIV-1 serodiagnosis in high-prevalence African settings Rapid testing strategies for HIV-1 serodiagnosis in high-prevalence African settings Wright R J, Stringer J S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed

2004 NHS Economic Evaluation Database.

124. Antiretroviral resistance testing in HIV patients

Antiretroviral resistance testing in HIV patients Antiretroviral resistance testing in HIV patients Antiretroviral resistance testing in HIV patients Pichon Riviere A, Augustovski F, Regueiro A, Garcia Marti S, Glujovsky D Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Pichon Riviere A, Augustovski F, Regueiro A, Garcia Marti S (...) , Glujovsky D. Antiretroviral resistance testing in HIV patients. Ciudad de Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS) 2004 Authors' objectives The aim of this report is to evaluate the diagnostic-therapeutic usefulness of antiretroviral resistance testing and its implications in the clinical practice. Authors' conclusions The HIV-1 genotype and phenotype resistance testing are part of the diagnostic-therapeutic tools currently available for the management of HIV patients

2004 Health Technology Assessment (HTA) Database.

125. Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. (Abstract)

Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. Acute human immunodeficiency virus (HIV) infection cannot be diagnosed by routine antibody tests and is rarely diagnosed in clinical practice. However, HIV nucleic acid-based testing is widely used to screen for antibody-negative acute infection among low-risk blood donors.To assess the feasibility of screening in high-volume laboratories for acute and long-term HIV infection in a routine (...) HIV testing population, in which HIV infection prevalence is low, using specimen pooling and HIV RNA reverse transcriptase-polymerase chain reaction (RT-PCR) tests.Clinical diagnostic performance evaluation at a state-funded public health virology and serology laboratory.A total of 8505 consecutive individuals presenting for routine HIV counseling and testing during a total of 20 business days to simulate a month of testing in August and December 2001 at 110 publicly funded testing sites in North

2002 JAMA

126. Anti-HIV-1 antibody testing using modified gelatin particle agglutination: a large field study

antibody testing using modified gelatin particle agglutination: a large field study. Journal of the Medical Association of Thailand 2001; 84(12): 1708-1713 PubMedID Other publications of related interest Wasi C, Louisirirotchanakul S, Kanoksinsombat C. Evaluation of two screening tests for anti-HIV: ELISA versus particle agglutination. Virus Inform Exch Newslett 1988;3:14. Behets F, Bertozzi S, Kasali M et al. Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development (...) of cost-effective models. AIDS 1990;4:737-41. Indexing Status Subject indexing assigned by NLM MeSH Agglutination Tests; Antibodies, Anti-Idiotypic /blood; Female; Gelatin; HIV Seropositivity /blood; HIV-1 /isolation & Humans; Male; Pregnancy; purification AccessionNumber 22002006472 Date bibliographic record published 31/05/2005 Date abstract record published 31/05/2005 NHS Economic Evaluation Database (NHS EED) Produced by the Centre for Reviews and Dissemination Copyright © 2019 University of York

2001 NHS Economic Evaluation Database.

127. Use of genotypic resistance testing to guide HIV therapy: clinical impact and cost-effectiveness

EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of genotypic antiretroviral resistance testing (GART) for drug-resistant strains of human immunodeficiency virus (HIV). Type of intervention Diagnosis. Economic study type Cost-utility analysis. Study population The study population comprised a hypothetical cohort of HIV-infected (...) Beirn Community Programs for Clinical Research on AIDS. AIDS 2000;14:F83-93. Tsevat J, Solzan JG, Kuntz KM, et al. Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning. Medical Care 1996;34:44-57. Indexing Status Subject indexing assigned by NLM MeSH Antiretroviral Therapy, Highly Active; Cost-Benefit Analysis; Genotype; HIV Infections /drug therapy /virology; HIV-1 /drug effects /genetics; Humans; Microbial Sensitivity Tests

2001 NHS Economic Evaluation Database.

128. Cost-effectiveness of HIV counseling and testing in US prisons Full Text available with Trip Pro

and the conclusions drawn. Health technology Human immunodeficiency virus (HIV) counselling and testing (CT) for prison inmates, at or near the time of their release from United States (US) prisons, was compared with no CT. Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis. Study population The study population was described as 10,000 prison inmates at or near their time of release from US prisons. Setting The setting was the community. The economic study was conducted (...) , or the effectiveness of counselling increased the magnitude of societal savings. HIV CT in US prisons remains less expensive than no HIV CT for society provided: HIV CT prevents 1.45 cases of HIV; the lifetime treatment costs of HIV infection exceed $40,000; and the risk of HIV transmission from infected to uninfected individuals is greater than 1% per year, and the risk of acquiring HIV for the uninfected is greater than 0.05% per year. Authors' conclusions Voluntary human immunodeficiency virus (HIV) counselling

2001 NHS Economic Evaluation Database.

129. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania

Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2000 NHS Economic Evaluation Database.

130. The cost-effectiveness of expanded HIV counselling and testing in primary care settings: a first look

of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of expanded counselling and testing (C&T) for human immunodeficiency virus (HIV) in primary care practices. Two options were investigated. First, requesting all patients to complete an HIV risk-screening instrument with C&T offered only to those patients disclosing a high risk (risk-history option). Second, the routine offering (...) for the identification of new human immunodeficiency virus (HIV) infections under the baseline assumptions. This result was sensitive to the assumptions in the baseline case. However, both strategies were preferred to the current practice. CRD COMMENTARY - Selection of comparators The comparator was chosen to reflect the diversity of current practice in the USA as a whole. This may limit the generalisability of the study since current practice would be expected to differ within and between countries. Validity

2000 NHS Economic Evaluation Database.

131. Cost effectiveness of expanded antenatal HIV testing in London

followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of expanded antenatal screening for human immunodeficiency virus (HIV). In addition to voluntary screening in early pregnancy, this study examines the use of repeat testing in late pregnancy, and partner testing in women who tested HIV-negative in early pregnancy, in order to find mothers who have acquired HIV in late pregnancy or while they are breast-feeding. Both universal (...) ) and only one transmission per 100,000 seronegative early pregnancies avoided. The results were sensitive to the testing cost. However, partner testing was cost-effective over the whole range of sensitivity analyses (4,700 was the maximum cost per life-year gained), and was cost-saving in many scenarios. Repeat testing was less cost-effective in the baseline scenario, except when the marginal cost of counselling was very low. Authors' conclusions Expanded antenatal screening for human immunodeficiency

2000 NHS Economic Evaluation Database.

132. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group. (Abstract)

Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Our aim was to determine the efficacy of HIV-1 voluntary counselling and testing (VCT) in reducing unprotected intercourse among individuals and sex-partner couples in Nairobi (Kenya), Dar es Salaam (Tanzania), and Port of Spain (Trinidad).Individual or couple participants were randomly assigned HIV (...) intercourse with non-primary partners declined significantly more for those receiving VCT than those receiving health information (men, 35% reduction with VCT vs 13% reduction with health information; women, 39% reduction with VCT vs 17% reduction with health information), and these results were maintained at the second follow-up. Individual HIV-1-infected men were more likely than uninfected men to reduce unprotected intercourse with primary and non-primary partners, whereas HIV-1-infected women were

2000 Lancet Controlled trial quality: uncertain

133. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. (Abstract)

Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Access to HIV-1 voluntary counselling and testing (VCT) is severely limited in less-developed countries. We undertook a multisite trial of HIV-1 VCT to assess its impact, cost, and cost-effectiveness in less-developed country settings.The cost-effectiveness of HIV-1 VCT was estimated for a hypothetical cohort of 10000 people seeking VCT in urban east Africa. Outcomes (...) were modelled based on results from a randomised controlled trial of HIV-1 VCT in Tanzania and Kenya. Our main outcome measures included programme cost, number of HIV-1 infections averted, cost per HIV-1 infection averted, and cost per disability-adjusted life-year (DALY) saved. We also modelled the impact of targeting VCT by HIV-1 prevalence of the client population, and the proportion of clients who receive VCT as a couple compared with as individuals. Sensitivity analysis was done on all model

2000 Lancet Controlled trial quality: uncertain

134. Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a cost-effectiveness analysis

S, Rouse D J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus (HIV). Type of intervention Primary prevention. Economic study (...) Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a cost-effectiveness analysis Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a cost-effectiveness analysis Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a cost-effectiveness analysis Stringer J

1999 NHS Economic Evaluation Database.

135. The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care

-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care. American Journal of Obstetrics and Gynecology 1999; 181(5 Part 1): 1062-1071 PubMedID Indexing Status Subject indexing assigned by NLM MeSH Analysis of Variance; Anti-HIV Agents /economics /therapeutic use; Cost Savings; Cost-Benefit Analysis; Decision Trees; Female; HIV Infections /diagnosis /drug therapy /economics /transmission; Humans; Infectious Disease Transmission, Vertical (...) The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care Grobman W A, Garcia P M Record Status This is a critical abstract of an economic evaluation that meets

1999 NHS Economic Evaluation Database.

136. Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing

Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing Kelen G D, Shahan J B, Quinn T C Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract (...) between 18 and 55 years of age who were not known to have HIV infection were approached.1,448 patients (48%) consented, 981 to standard and 467 to rapid testing. In phase 2, the rapid test was offered to 146 of 267 enrolled patients.78 patients consented to rapid testing. In phase 3, 389 of 409 enrolled patients were tested with the use of the rapid test. Patients were excluded if they were not capable of providing informed consent, in medical extremis, unable to return for follow-up after completion

1999 NHS Economic Evaluation Database.

137. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997

Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997 Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997 Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997 Weinhardt L S, Carey M P, Johnson B T, Bickham N L Authors' objectives To assess the effects of HIV counselling and testing (HIV-CT) on sexual (...) risk behaviour. Searching MEDLINE and PsycLIT were searched from January 1985 to June 1997 using combinations of the following keywords: 'AIDS', 'HIV' 'test*', 'counseling', 'serodiagnosis', 'serostatus', 'sex*' and 'behavior'. The authors also handsearched the journals AIDS, AIDS Care, AIDS Education and Prevention, American Journal of Public Health, Health Psychology, Journal of the American Medical Association, and Sexually Transmitted Diseases for the years 1985 to 1997 and scanned

1999 DARE.

138. A randomised controlled trial of different approaches to universal antenatal HIV testing: uptake and acceptability. Annex: Antenatal HIV testing - assessment of a routine voluntary approach

A randomised controlled trial of different approaches to universal antenatal HIV testing: uptake and acceptability. Annex: Antenatal HIV testing - assessment of a routine voluntary approach A randomised controlled trial of different approaches to universal antenatal HIV testing: uptake and acceptability. Annex: Antenatal HIV testing - assessment of a routine voluntary approach A randomised controlled trial of different approaches to universal antenatal HIV testing: uptake and acceptability (...) . Annex: Antenatal HIV testing - assessment of a routine voluntary approach Simpson WM, Johnstone FD, Boyd FM, Goldberg DJ, Hart GJ, Gormley SM, Hamilton BA Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Simpson WM, Johnstone FD, Boyd FM, Goldberg DJ, Hart GJ, Gormley SM, Hamilton BA. A randomised controlled trial of different approaches

1999 Health Technology Assessment (HTA) Database.

139. Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test. Full Text available with Trip Pro

Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test. To determine the uptake and acceptability of different methods of a universal offer of voluntary HIV testing to pregnant women.Randomised controlled trial involving four combinations of written and verbal communication, followed by the direct offer of a test. The control group received no information and no direct offer of a test, although testing was available (...) on request.Hospital antenatal clinic covering most of the population of the city of Edinburgh.3024 pregnant women booking at the clinic over a 10 month period.Uptake of HIV testing and women's knowledge, satisfaction, and anxiety.Uptake rates were 6% for those in the control group and 35% for those directly offered the test. Neither the style of leaflet nor the length of discussion had an effect on uptake. Significant independent predictors of uptake were a direct test offer; the midwife seen; and being unmarried

1998 BMJ Controlled trial quality: uncertain

140. The cost-effectiveness of HIV testing: accounting for differential participation rates

The cost-effectiveness of HIV testing: accounting for differential participation rates The cost-effectiveness of HIV testing: accounting for differential participation rates The cost-effectiveness of HIV testing: accounting for differential participation rates Paltiel A D, Kaplan E H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology HIV testing. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population A hypothetical cohort of HIV-infected and uninfected individuals. Setting Hospital. The economic study was carried out in New Haven, Connecticut, USA. Dates to which data relate The main effectiveness data were taken from national surveillance surveys andseroprevalence studies conducted

1997 NHS Economic Evaluation Database.